142nd APHA Annual Meeting and Exposition

Annual Meeting Recordings are now available for purchase

300636
Inconsistencies by the U.S. Departments of Health Websites Regarding Anal Use of the Female Condom

142nd APHA Annual Meeting and Exposition (November 15 - November 19, 2014): http://www.apha.org/events-and-meetings/annual
Tuesday, November 18, 2014

Kristina Rodriguez, MPH , CUNY School of Public Health-Graduate Center, New York, NY
Christina Ventura-DiPersia, MPH , CUNY School of Public Health-Graduate Center, New York, NY
Michael LeVasseur , Drexel University School of Public Health, Epidemiology & Biostatistics, Philadelphia, PA
Elizabeth A. Kelvin, PhD , Epidemiology & Biostatistics Program, CUNY School of Public Health, Hunter College & the Graduate Center, New York, NY
Background:  The female condom (FC) is FDA approved to prevent pregnancy and sexually transmitted infections during vaginal intercourse, but not for use during anal intercourse. A number of studies document that a significant proportion of men who have sex with men use the FC for anal intercourse, but its safety and disease prevention efficacy are unknown.

Methods:  Two people independently reviewed the Department of Health (DOH)websites for 50 U.S. states and 29 major cities (population >500,000) regarding messages about anal use of the FC.

Results: Only forty-nine (62.0%) websites mentioned the FC at all, of which only 23 (46.9%) mentioned anal use.  Of those that mention anal use, 15 (65.2%) websites were supportive of this use, 7 (30.4%) were neutral, and 1 (4.3%) discouraged use.  Ten websites (43.5%) provided instructions for anal use of the FC; in 7 cases, the instructions indicated removal of the inner ring while 3 cases recommended leaving in.  Four websites suggested that the FC could be used for anal intercourse either by inserting it into the anus prior to sex or by putting it over the penis as with a male condom.

Conclusions: In the U.S., the state and city DOH websites are an indispensible tool in providing delivery of public health information, in particular, sensitive information such as sexual health. The contradictory messages and divergent use instructions on DOH websites are concerning and highlight the need for research studies to definitively answer questions about safety and optimal methods of use.   

Learning Areas:

Administer health education strategies, interventions and programs
Conduct evaluation related to programs, research, and other areas of practice
Planning of health education strategies, interventions, and programs
Public health or related laws, regulations, standards, or guidelines

Learning Objectives:
Describe information, recommendations and inconsistencies regarding the use of the female condom for anal intercourse as provided by the U.S. Department of Health’s website in 50 states and 29 major cities.

Keyword(s): HIV Interventions, Sexual Risk Behavior

Presenting author's disclosure statement:
Organization/institution whose products or services will be discussed: Anal use of the female condom is unlabeled as the female condom is only FDA approved for vaginal use.

Qualified on the content I am responsible for because: I have participated in various quantitative clinical research projects addressing issues of HIV-1 pathogenesis and treatment. Recently, I have been co-investigator in a mixed methods research project investigating attitudes towards and behavioral correlates of interest in long-acting PrEP among MSM. In addition, I am a doctoral student at the CUNY graduate center.
Any relevant financial relationships? No

I agree to comply with the American Public Health Association Conflict of Interest and Commercial Support Guidelines, and to disclose to the participants any off-label or experimental uses of a commercial product or service discussed in my presentation.